New knee surgery pain plan aims to ditch opioids
NCT ID NCT03974932
Summary
This study tested a planned, non-opioid approach to managing pain after total knee replacement surgery. All 116 participants received an experimental long-acting numbing medicine (HTX-011) as part of a scheduled multi-drug plan. The main goal was to see how well this approach controlled pain and whether it could help patients recover without needing strong opioid painkillers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANALGESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Endeavor Clinical Trials, LLC.
San Antonio, Texas, 78229, United States
-
First Surgical Hospital
Bellaire, Texas, 77401, United States
-
Helen Keller Hospital
Sheffield, Alabama, 35660, United States
-
Midwest Clinical Research Center, LLC
Dayton, Ohio, 45417, United States
-
Phoenix Clinical Research, LLC
Tamarac, Florida, 33321, United States
-
Plano Surgical Hospital
Plano, Texas, 75093, United States
Conditions
Explore the condition pages connected to this study.